Consolidated Statements of Operations - USD ($) $ in Thousands		3 Months Ended
		Mar. 31, 2023	Mar. 31, 2022
Revenue
Total revenue		$ 12,837	$ 15,551
Cost of revenue		7,734	9,810
Gross profit		5,103	5,741
Operating expenses
Sales and marketing		5,051	6,665
Research and development		2,458	4,479
General and administrative		7,023	9,333
Total operating expenses		14,532	20,477
Loss from operations		(9,429)	(14,736)
Other income and expenses
Interest income		9	17
Interest expense		(637)	(451)
Foreign currency exchange transaction income (loss)		468	(827)
Total other expenses		(160)	(1,261)
Loss before income taxes		(9,589)	(15,997)
Income tax (benefit) provision		(18)	34
Net loss		$ (9,571)	$ (16,031)
Net loss per share - basic (in dollars per share)	[1]	$ (1.32)	$ (2.24)
Net loss per share - diluted (in dollars per share)	[1]	$ (1.32)	$ (2.24)
Weighted average common shares outstanding - basic (in shares)	[1]	7,253,645	7,167,171
Weighted average common shares outstanding - diluted (in shares)	[1]	7,253,645	7,167,171
Product
Revenue
Total revenue		$ 12,691	$ 14,884
Royalty and licensing
Revenue
Total revenue		$ 146	$ 667

[1] *Adjusted for the 1-for-25 reverse stock split